Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Daniel D De Carvalho
Affiliation
Princess Margaret Cancer Centre, University Health Network
ORCID
Career Start Year
2010
Papers
63
H Index
31
Expertise
CM4AI Collaborator
PMID
Paper Title
Journal Title
Published Year
37726227
Ratio of stemness to interferon signalling as a biomarker and therapeutic target of myeloproliferative neoplasm progression to acute myeloid leukaemia.
Br J Haematol
2024
36455236
Cerebrospinal fluid methylome-based liquid biopsies for accurate malignant brain neoplasm classification.
Neuro Oncol
2023
37600767
The chromatin and single-cell transcriptional landscapes of CD4 T cells in inflammatory bowel disease link risk loci with a proinflammatory Th17 cell population.
Front Immunol
2023
37244935
macroH2A2 antagonizes epigenetic programs of stemness in glioblastoma.
Nat Commun
2023
35263585
Identification of the global miR-130a targetome reveals a role for TBL1XR1 in hematopoietic stem cell self-renewal and t(8;21) AML.
Cell Rep
2022
35578032
PRMT inhibition induces a viral mimicry response in triple-negative breast cancer.
Nat Chem Biol
2022
36425756
Cell-free DNA methylation-defined prognostic subgroups in small-cell lung cancer identified by leukocyte methylation subtraction.
iScience
2022
36309516
The cell-free DNA methylome captures distinctions between localized and metastatic prostate tumors.
Nat Commun
2022
35311997
Epigenetic Activation of Plasmacytoid DCs Drives IFNAR-Dependent Therapeutic Differentiation of AML.
Cancer Discov
2022
33440135
Spliceosome-Targeted Therapies Induce dsRNA Responses.
Immunity
2021
33654322
Publisher Correction: Epigenetic therapy induces transcription of inverted SINEs and ADAR1 dependency.
Nature
2021
33609448
DNA hypomethylating agents increase activation and cytolytic activity of CD8<sup>+</sup> TÂ cells.
Mol Cell
2021
34433969
A clinically applicable integrative molecular classification of meningiomas.
Nature
2021
34649957
Endogenous Retroelements and the Viral Mimicry Response in Cancer Therapy and Cellular Homeostasis.
Cancer Discov
2021
33420488
Single-cell analysis reveals transcriptomic remodellings in distinct cell types that contribute to human prostate cancer progression.
Nat Cell Biol
2021
33242413
The Transition from Quiescent to Activated States in Human Hematopoietic Stem Cells Is Governed by Dynamic 3D Genome Reorganization.
Cell Stem Cell
2021
31626871
The role of DNA-demethylating agents in cancer therapy.
Pharmacol Ther
2020
33087935
Epigenetic therapy induces transcription of inverted SINEs and ADAR1 dependency.
Nature
2020
32938917
Haploinsufficiency of RREB1 causes a Noonan-like RASopathy via epigenetic reprogramming of RAS-MAPK pathway genes.
Nat Commun
2020
32992153
Paediatric Strategy Forum for medicinal product development of epigenetic modifiers for children: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration.
Eur J Cancer
2020
32669707
Nucleolar RNA polymerase II drives ribosome biogenesis.
Nature
2020
32753546
An open-label, phase II multicohort study of an oral hypomethylating agent CC-486 and durvalumab in advanced solid tumors.
J Immunother Cancer
2020
32178828
Using epigenetic data to estimate immune composition in admixed samples.
Methods Enzymol
2020
32546577
Epigenetic Switch-Induced Viral Mimicry Evasion in Chemotherapy-Resistant Breast Cancer.
Cancer Discov
2020
32299104
Mitochondrial carrier homolog 2 is necessary for AML survival.
Blood
2020
31173706
The Mitochondrial Transacylase, Tafazzin, Regulates AML Stemness by Modulating Intracellular Levels of Phospholipids.
Cell Stem Cell
2019
31727248
Methods to detect endogenous dsRNA induction and recognition.
Methods Enzymol
2019
30153961
The Cancer Epigenome: Exploiting Its Vulnerabilities for Immunotherapy.
Trends Cell Biol
2019
31526762
Pervasive H3K27 Acetylation Leads to ERV Expression and a Therapeutic Vulnerability in H3K27M Gliomas.
Cancer Cell
2019
30926792
Targeting bivalency de-represses Indian Hedgehog and inhibits self-renewal of colorectal cancer-initiating cells.
Nat Commun
2019
30723290
Epigenetic therapy in immune-oncology.
Nat Rev Cancer
2019
29760532
Apoptotic cell-induced AhR activity is required for immunological tolerance and suppression of systemic lupus erythematosus in mice and humans.
Nat Immunol
2018
29937226
LSD1 Ablation Stimulates Anti-tumor Immunity and Enables Checkpoint Blockade.
Cell
2018
30064665
Deregulation of Retroelements as an Emerging Therapeutic Opportunity in Cancer.
Trends Cancer
2018
29921600
Mammary molecular portraits reveal lineage-specific features and progenitor cell vulnerabilities.
J Cell Biol
2018
30429608
Sensitive tumour detection and classification using plasma cell-free DNA methylomes.
Nature
2018
28034915
Early-life antibiotic treatment enhances the pathogenicity of CD4<sup>+</sup> T cells during intestinal inflammation.
J Leukoc Biol
2017
28150715
Epigenetic regulation of nitric oxide synthase 2, inducible (Nos2) by NLRC4 inflammasomes involves PARP1 cleavage.
Sci Rep
2017
29580435
Cell-free DNA as a post-treatment surveillance strategy: current status.
Semin Oncol
2017
28943328
O-Acetylation of Peptidoglycan Limits Helper T Cell Priming and Permits Staphylococcus aureus Reinfection.
Cell Host Microbe
2017
29142897
Drug-induced activation of "junk" DNA - A path to combat cancer therapy resistance?
Oncoscience
2017
29022901
BCR-ABL1-induced downregulation of WASP in chronic myeloid leukemia involves epigenetic modification and contributes to malignancy.
Cell Death Dis
2017
26908456
Pre-neoplastic epigenetic disruption of transcriptional enhancers in chronic inflammation.
Oncotarget
2016
27960086
Integrated (epi)-Genomic Analyses Identify Subgroup-Specific Therapeutic Targets in CNS Rhabdoid Tumors.
Cancer Cell
2016
27424808
Mutant IDH1 Downregulates ATM and Alters DNA Repair and Sensitivity to DNA Damage Independent of TET2.
Cancer Cell
2016
26166478
Symmetrical Dose-Dependent DNA-Methylation Profiles in Children with Deletion or Duplication of 7q11.23.
Am J Hum Genet
2015
26317465
DNA-Demethylating Agents Target Colorectal Cancer Cells by Inducing Viral Mimicry by Endogenous Transcripts.
Cell
2015
27141349
Pharmacological DNA demethylation: Implications for cancer immunotherapy.
Oncoimmunology
2015
26208902
IL17 Promotes Mammary Tumor Progression by Changing the Behavior of Tumor Cells and Eliciting Tumorigenic Neutrophils Recruitment.
Cancer Res
2015
24959746
Constitutive androstane receptor ligands modulate the anti-tumor efficacy of paclitaxel in non-small cell lung cancer cells.
PLoS One
2014
1 - 50 of 63
Column Actions
Search
Recommended Authors
Hui Shen
Van Andel Institute
Career Start Year
2010
Number of shared co-authors
4
Benjamin G Barwick
Emory University School of Medicine
Career Start Year
2009
Number of shared co-authors
0
Lukas Chavez
University of California San Diego
Career Start Year
2008
Number of shared co-authors
24
Yassen Assenov
German Cancer Research Center (DKFZ)
Career Start Year
2006
Number of shared co-authors
3
Yue Lu
The University of Texas MD Anderson Cancer Center
Career Start Year
2006
Number of shared co-authors
1
Claudia Gebhard
University Hospital Regensburg
Career Start Year
2006
Number of shared co-authors
0
Linghua Wang
The University of Texas M. D. Anderson
Career Start Year
2006
Number of shared co-authors
4
Jingmin Shu
College of Health Solutions, Arizona State University
Career Start Year
2006
Number of shared co-authors
1
Richard Koche
Memorial Sloan Kettering Cancer Center
Career Start Year
2005
Number of shared co-authors
2
David Klinkebiel
University of Nebraska Medical Center
Career Start Year
2005
Number of shared co-authors
0
Maggie Cam
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year
2005
Number of shared co-authors
0
Anderly C Chueh
Biomedicine Discovery Institute, Monash University
Career Start Year
2005
Number of shared co-authors
1
Stefan Kubicek
CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences
Career Start Year
2003
Number of shared co-authors
4
Andrew V Kossenkov
The Wistar Institute
Career Start Year
2003
Number of shared co-authors
3
Helai P Mohammad
Collegeville
Career Start Year
2003
Number of shared co-authors
3
Robert Brown
Ovarian Cancer Action Research Centre, Imperial College London
Career Start Year
2002
Number of shared co-authors
1
Michael Slifker
Fox Chase Cancer Center
Career Start Year
2002
Number of shared co-authors
0
Ernesto Guccione
Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai
Career Start Year
2001
Number of shared co-authors
7
Ludmila Danilova
Bloomberg-Kimmel Immunotherapy Institute, Johns Hopkins University School of Medicine
Career Start Year
2001
Number of shared co-authors
2
Michal R Schweiger
Institute for Translational Epigenetics, University of Cologne
Career Start Year
1999
Number of shared co-authors
1
Joyce E Ohm
Roswell Park Comprehensive Cancer Center
Career Start Year
1999
Number of shared co-authors
1
Francine E Garrett-Bakelman
University of Virginia
Career Start Year
1999
Number of shared co-authors
2
Tim H-M Huang
University of Texas Health San Antonio (UTHSA)
Career Start Year
1997
Number of shared co-authors
2
Timothy A Chan
Cleveland Clinic.
Career Start Year
1994
Number of shared co-authors
6
Jean-Pierre J Issa
Fels Cancer Institute for Personalized Medicine, Temple University School of Medicine
Career Start Year
1993
Number of shared co-authors
5
Joseph F Costello
University of California san francisco
Career Start Year
1991
Number of shared co-authors
17
Holger Heyn
Barcelona Institute of Science and Technology, Spain Universitat Pompeu Fabra
Career Start Year
1988
Number of shared co-authors
5
Peter W Laird
Van Andel Institute
Career Start Year
1985
Number of shared co-authors
7
Kornel E Schuebel
National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health
Career Start Year
1985
Number of shared co-authors
1
Christoph Plass
German Cancer Research Center
Career Start Year
1982
Number of shared co-authors
18
row(s) 1 - 30 of 30
Collaborators
Helen Loo Yau
Princess Margaret Cancer Centre, University Health Network
Co-authored papers
13
Ankur Chakravarthy
Princess Margaret Cancer Centre, University Health Network
Co-authored papers
13
Mathieu Lupien
Princess Margaret Cancer Research Centre
Co-authored papers
12
Tiago da Silva Medina
International Research Center, A.C.Camargo Cancer Center
Co-authored papers
10
Rajat Singhania
Virginia Polytechnic Institute and State University
Co-authored papers
9
Charles A Ishak
Princess Margaret Cancer Centre, University Health Network
Co-authored papers
8
Cheryl H Arrowsmith
University of Toronto
Co-authored papers
8
Alex Murison
Princess Margaret Cancer Centre, University Health Network
Co-authored papers
6
Gary D Bader
University of Toronto
Co-authored papers
6
Housheng Hansen He
Princess Margaret Cancer Center, University Health Network, University of Toronto
Co-authored papers
4
Sujun Chen
Princess Margaret Cancer Center/University Health Network
Co-authored papers
4
Trevor J Pugh
Princess Margaret Cancer Centre, University Health Network
Co-authored papers
4
David W Cescon
Princess Margaret Cancer Centre
Co-authored papers
4
Dalia Barsyte-Lovejoy
University of Toronto, College St
Co-authored papers
4
Genevi??ve Deblois
Institute for Research in Immunology and Cancer (IRIC), University of Montreal
Co-authored papers
3
Nada Jabado
McGill University Health Centre (MUHC), Montreal Children's Hospital (MCH)
Co-authored papers
3
Paul C Boutros
University of California los angeles
Co-authored papers
3
Paul Guilhamon
The Hospital for Sick Children
Co-authored papers
3
Ken J Kron
Princess Margaret Cancer Centre, University Health Network
Co-authored papers
3
Peter B Dirks
The Hospital for Sick Children, University of Toronto
Co-authored papers
3
John E Dick
Princess Margaret Cancer Centre, University Health Network
Co-authored papers
2
Theodorus H van der Kwast
University Health Network, University of Toronto
Co-authored papers
2
Jennifer Cruickshank
Princess Margaret Cancer Centre, University Health Network
Co-authored papers
2
Farshad Nassiri
Toronto Western Hospital, University Health Network, University of Toronto
Co-authored papers
2
Thomas Kislinger
Princess Margaret Cancer Centre, University Health Network, University of Toronto
Co-authored papers
2
Philippe L Bedard
Princess Margaret Cancer Centre, University Health Network
Co-authored papers
2
Wail Ba-Alawi
Princess Margaret Cancer Centre, University Health Network, University Ave.
Co-authored papers
2
Xianghong Jasmine Zhou
David Geffen School of Medicine, University of California at Los Angeles
Co-authored papers
2
Marcela Gronda
Princess Margaret Cancer Centre
Co-authored papers
2
Michael Fraser
Princess Margaret Cancer Centre, University Health Network
Co-authored papers
2
1 - 30